French assembly wants tighter rules on patient education
This article was originally published in Scrip
Executive Summary
Members of the French national assembly voted amendments last week to draft healthcare legislation that mainly rule out direct communication between pharmaceutical companies and patients. The amended proposals must be approved by the senate and the president before they can become law.